Glycemic Management
‘Remission’ best term to define return of normal glucose levels in type 2 diabetes
The term “remission” should be used to describe a person with type 2 diabetes who has achieved a disease-free status, according to a consensus report.
Longer diabetes duration lowers likelihood for meeting glycemic targets
People with a longer duration of diabetes are less likely to achieve glycemic targets, according to a study published in Journal of Diabetes and Its Complications.
Q&A: Taking breaks from sitting improves fasting glucose, glycemic variability
Frequent breaks from sitting for 3 weeks lowered fasting glucose and glycemic variability in adults with obesity, according to findings published in the American Journal of Physiology.
HbA1c poor marker for all-cause mortality in adults with high glycemic variability
HbA1c may not be a robust marker for all-cause mortality among adults with type 2 diabetes and a high degree of glycemic variability, suggesting new metrics assessing glycemic response are needed.
HbA1c variability increases mortality risk in diabetes
Adults with diabetes in Israel had an increased mortality risk with higher variability in HbA1c levels over a period of 5 years, according to a study published in Diabetes/Metabolism Research and Reviews.
Top in endocrinology: Oral anticoagulants and bone density, glycemic control trends
Researchers said that a new study examining the impact of oral anticoagulants on bone health underscores the importance of assessing patients who are taking these medications for bone mineral density and quality.
More youths with type 1 diabetes meet time-in-range goal with hybrid closed-loop system
The percentage of youths with type 1 diabetes spending at least 70% time in range more than doubled after 3 months of using a hybrid closed-loop insulin delivery system, according to a study published in Diabetes Technology & Therapeutics.
Mean glycemic gap best predicts ICU mortality odds in adults with diabetes
Adults with diabetes admitted to two ICUs in China were less likely to survive if they had a larger gap between mean blood glucose 7 days after ICU admission and HbA1c-derived average glucose, according to study data.
Adding CGM data to EHR could boost use in primary care diabetes management
A pilot process that incorporates patients’ continuous glucose monitoring data directly into the electronic health record improved clinician access to valuable glucose information and should be expanded, according to a speaker.
Pramlintide-insulin co-formulation improves time in range in type 1 diabetes
ADO09, a co-formulation of pramlintide and insulin A21G, was associated with better glucose levels, improved time in range and more weight loss among people with type 1 diabetes compared with insulin aspart, according to a presenter.